🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Status
Terminated
Location
University of California Los Angeles
Start Date
2010-12
Trial ID
NCT01261299
Treatments Being Tested
This case-control study will be conducted between January and June 2026 and...
Status
Enrolling By Invitation
Location
University of babylon
Start Date
2026-01-31
Trial ID
NCT07579338
The primary objective of this study is to determine the effectiveness and s...
Status
Unknown
Location
Mack Eye Center
Start Date
2013-10
Trial ID
NCT02009709
Treatments Being Tested
The Personalized Discovery Process is the only program offering patients tr...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-01
Trial ID
NCT02363647
Treatments Being Tested
RATIONALE: Studying samples of DNA in the laboratory from women who are BRC...
Status
Unknown
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-04
Trial ID
NCT00897455
This prospective cohort study aims to identify immune-related predictive fa...
Status
Active Not Recruiting
Location
Institute of Oncology Ljubljana
Start Date
2017-03-01
Trial ID
NCT07407244
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested
Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Status
Completed
Location
AOU Careggi- University of Florence
Start Date
2021-03-24
Trial ID
NCT04806906
Treatments Being Tested